concept

AMI

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AMI: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

114Connections
29Hypotheses
0Analyses
0Outgoing
50Incoming
10Experiments
0Debates

Summary

AMI is a concept in neurodegeneration research. Key relationships include: implicated in, associated with. Connected to 113 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

💡 Concept Info
NameAMI
Key Genes/ProteinsA2M, ABCA1, ABCG1, ACTB, AKT, ALS

Pathway Diagram

graph TD
    AMI["AMI"]
    MAP1B["MAP1B"] -->|"implicated in"| AMI
    MAP2["MAP2"] -->|"implicated in"| AMI
    MAP6["MAP6"] -->|"implicated in"| AMI
    RAB7A["RAB7A"] -->|"implicated in"| AMI
    LRP2["LRP2"] -->|"implicated in"| AMI
    ACTB["ACTB"] -->|"implicated in"| AMI
    CTSD["CTSD"] -->|"implicated in"| AMI
    ATG["ATG"] -->|"implicated in"| AMI
    EGFR["EGFR"] -->|"implicated in"| AMI
    SREBF1["SREBF1"] -->|"implicated in"| AMI

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (114)

SourceRelationTypeStr
MMP9associated_withprotein0.72
41484454has neuroprotective effects throughpaper0.60
IDH1implicated_ingene0.50
MCUimplicated_ingene0.50
LETM1implicated_ingene0.50

Targeting Hypotheses (29)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Palmitoylethanolamide-Based Endocannabinoid Therapy 0.919 - Blood-brain barrier tight junction disru
Sequential Iron Chelation (Deferoxamine) and GPX4 Restoratio 0.838 neurodegeneration View
CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind 0.801 neuroimmunology TREM2 in Alzheimer's Disease: Mechanisms
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A 0.790 neurodegeneration epigenetic reprogramming aging neurons
Tau/MAP6 ratio as a master switch for microtubule dynamics p 0.750 neurodegeneration View
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio 0.740 neuroscience Circuit-level neural dynamics in neurode
SMPD1 (Acid Sphingomyelinase) Inhibition for Ceramide Reduct 0.732 neurodegeneration How do sphingomyelin/ceramide ratios spe
TDP-43 condensation thermodynamics as a therapeutic target a 0.710 neuroscience How can subcellular compartmentalization
CD8+ T-Cell Perforin Pathway as Driver of Neuronal Pyramid L 0.710 Alzheimer's disease, Parkinson's disease -
Ataxin-2 Polyglutamine Expansions Hijack G3BP1 to Form Toxic 0.700 neurodegeneration How do disease-associated mutations in G
Lysosomal Positioning Dynamics Modulation 0.686 neurodegeneration Autophagy-lysosome pathway convergence a
Bacterial Tyramine–Induced DOPAL Accumulation in Enteric Neu 0.680 neurodegeneration What are the mechanisms by which gut mic
Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification 0.677 translational neuroscience Which metabolic biomarkers can distingui
Lipid Droplet Dynamics as Phenotype Switches 0.666 neurodegeneration Astrocyte reactivity subtypes in neurode
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio 0.665 translational neuroscience Which metabolic biomarkers can distingui
Mitochondrial Biogenesis Rate as a Dynamic Biomarker of Neur 0.652 translational neuroscience Which metabolic biomarkers can distingui
Transglutaminase-2 Cross-Linking Inhibition Strategy 0.639 neurodegeneration Protein aggregation cross-seeding across
BH4 Cofactor Restoration as Primary Driver of >500-Fold Dopa 0.618 neurodegeneration What molecular mechanisms underlie Atrem
Correcting Gut Microbial Dopamine Imbalance to Support Syste 0.606 neurodegeneration What are the mechanisms by which gut mic
Glycosaminoglycan Template Disruption Approach 0.597 neurodegeneration Protein aggregation cross-seeding across
Dynamic Microglial Phenotype Switching Biomarker Panel for N 0.577 neurodegeneration What amyloid threshold level is required
HCN1-Selective Blockade Normalizes Thalamic Rebound Bursting 0.526 synaptic biology How do P/Q channel deficits paradoxicall
Lamin B1 Degradation as Irreversibility Gate 0.523 molecular biology What is the optimal therapeutic window t
Loss of Nuclear Lamin B1 Distinguishes Senescent Microglia f 0.520 neurodegeneration How can senescent microglia be molecular
Lamin B1 Restoration Prevents Age-Related Nuclear Lamina Com 0.510 neurodegeneration Investigate mechanisms of epigenetic rep
Small-Molecule Modulation of G3BP1 Condensate Dynamics via P 0.400 neurodegeneration How do disease-associated mutations in G
Branched-Chain Amino Acid Transamination Inhibition to Modul 0.400 metabolomics Metabolomic signatures of neurodegenerat
Exposure profile may matter more than nominal daily dose, bu 0.390 neurodegeneration -
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis 0.384 neurodegeneration What are the mechanisms by which gut mic

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (10)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Plasma ATN biomarkers across AD continuum in Chilean cohort clinical Alzheimer's disease 0.950 0.00 Chilean older adults (n=318) w proposed N/A
Autophagy receptor identification for stress granule elimination exploratory neurodegenerative diseases 0.900 0.00 cultured cells under arsenite proposed N/A
Epigenetic clocks association with brain aging patterns in older women exploratory cognitive impairment and demen 0.900 0.00 human patients proposed N/A
Tau depletion effects on neuronal development in primary cultures exploratory 0.900 0.00 primary rodent neuronal cultur proposed N/A
Differential GWAS of schizophrenia vs PTSD exploratory schizophrenia, post-traumatic 0.900 0.00 human patients - European ance proposed N/A
Tau depletion effects on neuronal development in primary cultures exploratory 0.900 0.00 primary rodent neuronal cultur proposed N/A
Creation and validation of 3xAD-ChAT-Cre mouse model validation Alzheimer's disease 0.900 0.00 3xAD-ChAT-Cre transgenic mice proposed N/A
GTEx brain tissue expression analysis of MAPT/CRHR1 locus exploratory schizophrenia, post-traumatic 0.850 0.00 human brain tissue samples fro proposed N/A
Microtubule domain analysis in adult axons exploratory 0.800 0.00 adult rodent axons proposed N/A
Tau depletion effects on microtubule domains in adult axons exploratory 0.800 0.00 adult rodent neurons proposed N/A

Related Papers (18)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Pathogenic Variants and Olipudase Alfa Treatment of Patients With Acid Sphingomy [PMID:41692468] ["Hsu-Heng Lin", "Hui-An Chen", "Shyh-Je Molecular genetics & genom 2026 0
Multi-omics analysis identifies SMPD1 as a key contributor in sphingolipid pathw [PMID:41428198] ["Aron Park", "Baeki E Kang", "Eun-Ju Ji Genes & genomics 2026 0
Mammalian lipophagy: process and function. [PMID:41681129] Zhao R, Dai E, Kang R, Liu J, Klionsky D Autophagy 2026 0
A multi-dimensional bioinformatic dissection of the molecular mechanisms in high [PMID:41191606] Yu X MD, Lei J MSc, Du X MSc, He Y MSc, Int J Surg 2026 0
Plasma metabolites may inhibit childhood obesity by regulating ferroptosis throu [PMID:41249848] Wang JG, Pan XH, Li Y Int J Obes (Lond) 2026 0
Multi-omics analysis identifies SMPD1 as a key contributor in sphingolipid pathw [PMID:41428198] Park A, Kang BE, Jin EJ, Kim HJ, Lee CW Genes Genomics 2026 0
AXL Promotes Ischemic Myelin Repair Through Alleviating Myelin Debris Deposition [PMID:41524160] Jia J, Gan Y, Li J, Li L, Meng H et al. Adv Sci (Weinh) 2026 0
Pathogenic Variants and Olipudase Alfa Treatment of Patients With Acid Sphingomy [PMID:41692468] Lin HH, Chen HA, Lin SJ, Hsu RH, Lee NC Mol Genet Genomic Med 2026 0
AXL Promotes Ischemic Myelin Repair Through Alleviating Myelin Debris Deposition [PMID:41524160] Jia J, Gan Y, Li J, Li L, Meng H, Sun M, Advanced science (Weinheim, Ba 2026 0
A multi-dimensional bioinformatic dissection of the molecular mechanisms in high [PMID:41191606] Yu X, Lei J, Du X, He Y, Peng W, Yang R, International journal of surge 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Di [PMID:39000217] Unknown International journal of molec 2024 0
Neurodegeneration and demyelination in multiple sclerosis. [PMID:38889714] Garton T, Gadani SP, Gill AJ, Calabresi Neuron 2024 0
STING orchestrates the neuronal inflammatory stress response in multiple scleros [PMID:38878778] Woo MS, Mayer C, Binkle-Ladisch L, Sonne Cell 2024 0
Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. [PMID:36917977] Neel DV, Basu H, Gunner G, Bergstresser Neuron 2023 0
Pyrethroid exposure and neurotoxicity: a mechanistic approach. [PMID:31246571] Unknown Arhiv za higijenu rada i toksi 2020 0
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] Marogianni C, Sokratous M, Dardiotis E, International journal of molec 2020 0
Multiple Sclerosis Pathology. [PMID:29358320] Lassmann H Cold Spring Harbor perspective 2018 0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning AMI in their description or question text

Dopaminergic Ventral Tegmental-Hippocampal Circuit Protection

Score: 0.740 · neuroscience · 2026-04-07

## Mechanistic Overview Dopaminergic Ventral Tegmental-Hippocampal Circuit Protection starts from the claim that modulat

SMPD1 (Acid Sphingomyelinase) Inhibition for Ceramide Reduction and BACE1 Regula

Score: 0.732 · neurodegeneration · 2026-04-16

**Molecular Mechanism and Rationale** The molecular foundation for SMPD1 inhibition in Alzheimer's disease centers on t

TDP-43 condensation thermodynamics as a therapeutic target and biomarker for nuc

Score: 0.710 · neuroscience · 2026-04-26

FRAP-based measurement of TDP-43 liquid-liquid phase separation state provides a continuous biomarker of nuclear-cytopla

Ataxin-2 Polyglutamine Expansions Hijack G3BP1 to Form Toxic, Irreversible Stres

Score: 0.700 · neurodegeneration · 2026-04-22

## Mechanistic Overview Ataxin-2 Polyglutamine Expansions Hijack G3BP1 to Form Toxic, Irreversible Stress Granule Comple

Lysosomal Positioning Dynamics Modulation

Score: 0.686 · neurodegeneration · 2026-04-02

## Mechanistic Overview Lysosomal Positioning Dynamics Modulation starts from the claim that modulating LAMP1 within the

Bacterial Tyramine–Induced DOPAL Accumulation in Enteric Neurons

Score: 0.680 · neurodegeneration · 2026-04-22

## **Molecular Mechanism and Rationale** The proposed mechanism centers on a complex interplay between gut microbiota,

Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification Biomarker

Score: 0.677 · translational neuroscience · 2026-04-16

## Mechanistic Overview Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification Biomarker starts from the claim tha

Lipid Droplet Dynamics as Phenotype Switches

Score: 0.666 · neurodegeneration · 2026-04-02

## Mechanistic Overview Lipid Droplet Dynamics as Phenotype Switches starts from the claim that modulating DGAT1 and SOA

Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interfa

Score: 0.665 · translational neuroscience · 2026-04-12

## Mechanistic Overview Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker sta

Mitochondrial Biogenesis Rate as a Dynamic Biomarker of Neuroprotection

Score: 0.652 · translational neuroscience · 2026-04-12

## Mechanistic Overview Mitochondrial Biogenesis Rate as a Dynamic Biomarker of Neuroprotection starts from the claim th

Transglutaminase-2 Cross-Linking Inhibition Strategy

Score: 0.639 · neurodegeneration · 2026-04-02

Transglutaminase-2 creates covalent cross-links between lysine and glutamine residues shared across tau, α-synuclein, an

BH4 Cofactor Restoration as Primary Driver of >500-Fold Dopamine Elevation

Score: 0.618 · neurodegeneration · 2026-04-13

## Mechanistic Overview BH4 Cofactor Restoration as Primary Driver of >500-Fold Dopamine Elevation starts from the claim

Correcting Gut Microbial Dopamine Imbalance to Support Systemic Dopaminergic Fun

Score: 0.606 · neurodegeneration · 2026-04-02

## Mechanistic Overview Correcting Gut Microbial Dopamine Imbalance to Support Systemic Dopaminergic Function starts fro

Glycosaminoglycan Template Disruption Approach

Score: 0.597 · neurodegeneration · 2026-04-02

Heparan sulfate and other glycosaminoglycans serve as nucleation templates that facilitate cross-seeding by concentratin